EcoDrugPlus


Synonyms	Camin Diethylcarbamazine Hetrazan
Status
Molecule Category	Free-form
ATC	P02CB02
UNII	V867Q8X3ZD
EPA CompTox	DTXSID1022928

Synonyms

Camin

Diethylcarbamazine

Hetrazan

Status

Molecule Category

Free-form

ATC

P02CB02

UNII

V867Q8X3ZD

EPA CompTox

DTXSID1022928


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	RCKMWOKWVGPNJF-UHFFFAOYSA-N
Smiles	CCN(CC)C(=O)N1CCN(C)CC1
InChI	InChI=1S/C10H21N3O/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13/h4-9H2,1-3H3

InChI Key

RCKMWOKWVGPNJF-UHFFFAOYSA-N

Smiles

CCN(CC)C(=O)N1CCN(C)CC1

InChI

InChI=1S/C10H21N3O/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13/h4-9H2,1-3H3

Resources	Reference
ChEBI	4527
ChEMBL	CHEMBL684
DrugBank	DB00711
DrugCentral	873
FDA SRS	V867Q8X3ZD
Human Metabolome Database	HMDB0014849
KEGG	C07968
PharmGKB	PA164748883
PubChem	3052
SureChEMBL	SCHEMBL67289
ZINC	ZINC000000001288

Resources

Reference

ChEBI

ChEMBL

DrugBank

DrugCentral

FDA SRS

Human Metabolome Database

KEGG

PharmGKB

PubChem

SureChEMBL

ZINC


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

DIETHYLCARBAMAZINE

Structure

Cross References